Header Logo

Connection

SHUBHAM PANT to Benzazepines

Back to Details
This is a "connection" page, showing publications SHUBHAM PANT has written about Benzazepines.
SHUBHAM PANT
Connection Strength
0.046
Benzazepines
  1. A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors. Invest New Drugs. 2021 08; 39(4):1089-1098.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.